Laura Corson
Dana-Farber/Boston Children's Cancer and Blood Disorders Center · 95 works · 3,835 citations · h-index 25
Top works
- Ctf7p is essential for sister chromatid cohesion and links mitotic chromosome structure to the DNA replication machinery
- Spatial and temporal patterns of ERK signaling during mouse embryogenesis
- Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants
- Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
- Variation in the Biochemical/Biophysical Properties of Mutant Superoxide Dismutase 1 Enzymes and the Rate of Disease Progression in Familial Amyotrophic Lateral Sclerosis Kindreds
- The Copper Chaperone CCS Is Abundant in Neurons and Astrocytes in Human and Rodent Brain
- Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors
- Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition
- Toxicity of ALS-Linked SOD1 Mutants
- An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer
- Ushering in the next generation of precision trials for pediatric cancer
- Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer
- Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase
- Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A–SF3b complex
- Characterization of Mouse Rsk4 as an Inhibitor of Fibroblast Growth Factor-RAS-Extracellular Signal-Regulated Kinase Signaling
- A Class of 2,4-Bisanilinopyrimidine Aurora A Inhibitors with Unusually High Selectivity against Aurora B
- Oxidative Stress and Iron Are Implicated in Fragmenting Vacuoles of Saccharomyces cerevisiae Lacking Cu,Zn-Superoxide Dismutase
- A Pentacyclic Aurora Kinase Inhibitor (AKI-001) with High in Vivo Potency and Oral Bioavailability
- Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase
- Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer